AbbVie (ABBV) director Falk awarded 1,118 restricted stock units, holds 2,321 shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
FALK THOMAS J reported acquisition or exercise transactions in this Form 4 filing.
AbbVie Inc. director Thomas J. Falk reported a compensation-related equity grant. He received 1,118 shares of AbbVie common stock at $0.00 per share as a grant of restricted stock units under the AbbVie Amended and Restated 2013 Incentive Stock Program. Following this award, he holds 2,321 AbbVie shares directly. The restricted stock units will be settled one-for-one in AbbVie shares upon the earlier of his separation from service, death, or a change in control as defined in the program. Separately, an additional 3,000 shares are owned indirectly through a limited partnership jointly controlled by Falk and his spouse, for which he disclaims beneficial ownership except for his pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
FALK THOMAS J
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock, $0.01 par value | 1,118 | $0.00 | -- |
| holding | Common Stock, $0.01 par value | -- | -- | -- |
Holdings After Transaction:
Common Stock, $0.01 par value — 2,321 shares (Direct, null);
Common Stock, $0.01 par value — 3,000 shares (Indirect, By limited partnership)
Footnotes (1)
- These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). The securities are owned by a limited partnership that is jointly controlled by the reporting person and his spouse. The reporting person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
Key Figures
RSU grant size: 1,118 shares
Grant price: $0.00 per share
Direct holdings after grant: 2,321 shares
+1 more
4 metrics
RSU grant size
1,118 shares
Restricted stock units awarded to director on 2026-05-08
Grant price
$0.00 per share
Price per share for RSU grant
Direct holdings after grant
2,321 shares
AbbVie common stock held directly after transaction
Indirect partnership holdings
3,000 shares
Owned by limited partnership jointly controlled with spouse
Key Terms
restricted stock units, change in control, pecuniary interest, limited partnership, +1 more
5 terms
restricted stock units financial
"These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
change in control financial
"on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control"
A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.
pecuniary interest financial
"disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein"
limited partnership financial
"The securities are owned by a limited partnership that is jointly controlled by the reporting person and his spouse"
A limited partnership is a legal business structure with two types of partners: at least one general partner who runs the business and bears full legal responsibility, and one or more limited partners who contribute money, share profits, and have liability capped at their investment. For investors, it matters because it separates control from financial exposure — like putting money into a store without managing it — and affects how returns, risks, taxes and transferability of ownership are handled.
Incentive Stock Program financial
"awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program"
FAQ
What insider transaction did AbbVie (ABBV) director Thomas J. Falk report?
Thomas J. Falk reported receiving a grant of 1,118 shares of AbbVie common stock as restricted stock units at $0.00 per share. This is a compensation-related award, not an open-market stock purchase or sale.
What are the terms of Thomas J. Falk’s AbbVie (ABBV) restricted stock units?
The restricted stock units will be paid one-for-one in AbbVie common shares. Settlement occurs on the earlier of Falk’s separation from service, death, or a change in control as defined in AbbVie’s 2013 Incentive Stock Program.
How are Thomas J. Falk’s indirect AbbVie (ABBV) holdings structured?
An additional 3,000 AbbVie shares are owned by a limited partnership jointly controlled by Falk and his spouse. Falk disclaims beneficial ownership of these securities except to the extent of his pecuniary interest in the partnership.